Medical News:%20FDA Warns of Clot Risk with Yaz, Other OCs - in Public Health & Policy, FDA General from MedPage Today: Labels for oral contraceptives that contain drospirenone will now note that studies have shown as much as a threefold increase in risk of blood clots compared with other birth control pills, the FDA said. The label changes apply to nine brand-name contraceptives -- Beyaz, Gianvi, Loryna, Ocella, Safyral, Syeda, Yasmin, Yaz, and Zarah -- and two generic formulations, all of which include 3 mg of drospirenone.
'via Blog this'
No comments:
Post a Comment